Advertisement

Topics

Adamis Pharmaceuticals (ADMP) vs. Impax Laboratories (IPXL) Head-To-Head Survey

12:29 EST 27 Jan 2018 | Topix

Adamis Pharmaceuticals and Impax Laboratories are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, profitability, risk and valuation. Adamis Pharmaceuticals has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500.

Original Article: Adamis Pharmaceuticals (ADMP) vs. Impax Laboratories (IPXL) Head-To-Head Survey

NEXT ARTICLE

More From BioPortfolio on "Adamis Pharmaceuticals (ADMP) vs. Impax Laboratories (IPXL) Head-To-Head Survey"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...